nsc-172755 has been researched along with rifampin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Anagonou, SY; Foundohou, J; Gninafon, M; Josse, R; Kinde-Gazard, D; Tawo, L | 1 |
| Aguiar, J; Debacker, M; Meyers, WM; Portaels, F; Steunou, C; Zinsou, C | 1 |
| Affolabi, D; Anagonou, S; Martin, A; Odoun, M; Palomino, JC; Portaels, F | 1 |
| Affolabi, D; Anagonou, S; Kestens, L; Koukpemedji, L; Martin, A; Odoun, M; Palomino, JC; Portaels, F; Sanoussi, N | 1 |
| Affolabi, D; Anagonou, SY; Asiedu, K; Barogui, YT; Dossou, AD; Johnson, CR; Portaels, F; Sopoh, GE; Zohoun, T | 1 |
| Adeye, A; Ardant, MF; Chauty, A; Cottin, J; Goundoté, A; Ji, B; Ladikpo, T; Landier, J; Marsollier, L; Pluschke, G; Ruf, T | 1 |
| Barogui, YT; Brun, LV; Dossou, AD; Johnson, RC; Pluschke, G; Ruf, MT; Sopoh, GE | 1 |
| Agbo, IE; Amoussouhoui, AS; Aoulou, P; Boyer, M; Houezo, JG; Johnson, RC; Nichter, M; Sopoh, GE; Wadagni, AC | 1 |
| Johnson, PDR | 1 |
| Abass, KM; Agossadou, D; Ampadu, EO; Asiedu, KB; Chauty, A; Egondi, TW; Frimpong, M; Ganlonon, L; Gateau, T; Grosset, J; Lehman, L; Macdonald, JM; Marion, E; Ochieng Otieno, M; Ohene, SA; Omollo, R; Paintsil, A; Phillips, RO; Robert, J; Saizonou, R; Sarfo, FS; Sarpong, G; Sarpong, NF; Saunderson, P; Stienstra, Y; Thompson, W; Tiendrebeogo, A; Treadwell, T; van der Werf, TS; Wansbrough-Jones, M; Wilson, T | 1 |
| Affolabi, D; Agbla, SC; Agodokpessi, G; de Jong, BC; Fandohan, M; Massou, F; Rigouts, L; Wachinou, AP | 1 |
| Addo, J; Anagonou, ES; Ayelo, AG; Biswas, N; Calderon, F; Cruz, I; Della Pasqua, O; Díez, G; Gine-March, A; Gnimavo, RS; Herrador, Z; Houezo, JG; Johnson, RC; Kpoton, GG; Mendoza-Losana, A; Mignanwande, FZ; Orford, L; Ramón-García, S; Sáez-López, E; Sopoh, GE; Vlasakakis, G | 1 |
2 trial(s) available for nsc-172755 and rifampin
| Article | Year |
|---|---|
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Ghana; Humans; Male; Rifampin; Streptomycin; Wound Healing; Young Adult | 2020 |
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled mu
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Benin; Buruli Ulcer; Clarithromycin; Clinical Trials, Phase II as Topic; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Treatment Outcome | 2022 |
11 other study(ies) available for nsc-172755 and rifampin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
[Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
Topics: Benin; Drug Resistance, Microbial; Ethambutol; Humans; Isoniazid; Mycobacterium; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1993 |
Buruli ulcer recurrence, Benin.
Topics: Anti-Bacterial Agents; Benin; Endemic Diseases; Follow-Up Studies; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Recurrence; Rifampin; Skin Diseases, Bacterial; Streptomycin | 2005 |
Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin.
Topics: Antitubercular Agents; Bacterial Proteins; Benin; Colorimetry; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Mycobacterium tuberculosis; Nitrate Reductase; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary | 2007 |
Rapid detection of multidrug-resistant Mycobacterium tuberculosis in Cotonou (Benin) using two low-cost colorimetric methods: resazurin and nitrate reductase assays.
Topics: Bacterial Proteins; Benin; Colorimetry; Drug Resistance, Bacterial; Drug Resistance, Multiple; Humans; Mycobacterium tuberculosis; Nitrate Reductase; Rifampin | 2008 |
Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycin.
Topics: Adult; Antibiotics, Antitubercular; Benin; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Skin Transplantation | 2008 |
Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Pilot Projects; Rifampin; Treatment Outcome; Young Adult | 2011 |
Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Benin; Biopsy; Buruli Ulcer; Child; Child, Preschool; Debridement; Drug Therapy; Female; Histocytochemistry; Humans; Immunohistochemistry; Male; Microscopy; Middle Aged; Mycobacterium ulcerans; Rifampin; Skin; Streptomycin; Treatment Outcome; Young Adult | 2011 |
Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
Topics: Anti-Bacterial Agents; Benin; Buruli Ulcer; Community Health Services; Disease Management; Early Medical Intervention; Female; Health Impact Assessment; Health Plan Implementation; Humans; Male; Mycobacterium ulcerans; Rifampin; Streptomycin | 2018 |
Surgery for Buruli ulcer in the antibiotic era.
Topics: Anti-Bacterial Agents; Benin; Buruli Ulcer; Humans; Mycobacterium ulcerans; Rifampin | 2018 |
Spot specimen testing with GeneXpert MTB/RIF results compared to morning specimen in a programmatic setting in Cotonou, Benin.
Topics: Benin; Drug Resistance, Bacterial; Humans; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum | 2021 |